# Osang Healthcare Co., Ltd.

- Location (FDA's records): Anyang, KR
- FDA decisions: 3 (2018–2021): 3 510(k) clearances
- Product codes: NBW (3)
- 510(k) review time since 2016: median 141 days, against 168 for FDA's reviews in the same codes and years (2 of 3 faster)
- Predicates its devices cite: 3 (1 its own); citations of its devices by later devices: 1 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Infopia Co, Ltd.: 2 (https://510kreport.com/company/infopia)

## Its most-cited devices
- K182286: Oh'Care Lite Smart Blood Glucose Monitoring System (2018), cited by 1

## Recent decisions
- K203562: Finetest Lite Blood Glucose Monitoring System (Jul 13, 2021)
- K201396: Finetest Lite Smart Blood Glucose Monitoring System (Oct 16, 2020)
- K182286: Oh'Care Lite Smart Blood Glucose Monitoring System (Sep 19, 2018)

Source page: https://510kreport.com/company/osang-healthcare